Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr Pimanda will present results from a body of work using functional genomics to develop tools to predict drug response in Myelodysplasia (MDS), identify alternate treatment options for patients who fail current treatment and characterise treatment related changes to the sub-clonal architecture and function of dysplastic haematopoietic stem/progenitor cells (HSPCs). He will also present an integrative analysis of long intergenic non-coding RNA (lincRNAs) expression from 922 acute myeloid leukemia patients. These analyses show that leukemic and normal hematopoietic cell subsets express distinct lincRNAs and that gene signatures composed of as few as three lincRNA genes are independent predictors of clinical outcome across multiple patient cohorts.
